A Long-term Safety Study of Once-daily Travatan

Completed · Phase 3

Conditions studied: Glaucoma, Open-angle, Ocular Hypertension

In brief

Long term safety study of TRAVATAN in patients with Open-angle glaucoma or ocular hypertension.

Key facts

Study ID

NCT00051168

Run by

Alcon Research

People needed

502

Starts

2006-01-01

Last updated by the study team

2011-10-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Europe — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.